Ann Phlebology.  2024 Jun;22(1):36-38. 10.37923/phle.2024.22.1.36.

My Experience and Comprehension of Flebogrif®, a New Modality of Mechanochemical Ablation for Incompetent Saphenous Veins – What’s Different from ClariVein®?

Affiliations
  • 1Charm Vascular Clinic, Seoul, Korea

Abstract

Flebogrif® is a new modality of mechanochemical ablation for incompetent saphenous vein treatment. With our experiences, it offers advantages such as reduced sclerosant dosage, shorter procedure times, lower catheter costs and in terms of closure rate as well. However, the potential for increased pain and thrombophlebitis due to more potent mechanical injury is apparent.

Keyword

Chronic venous disease; Mechanochemical ablation; Clarivein; Flebogrif
Full Text Links
  • AP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr